A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients

World Journal of Biological Psychiatry

Volumn 16, Issue 3, 2015, Pages 180-189

  Schwarz, Ricarda ^a   Reif, Andreas ^a   Scholz, Claus Jürgen ^a   Weissflog, Lena ^a   Schmidt, Brigitte ^a   Lesch, Klaus Peter ^a   Jacob, Christian ^c   Reichert, Susanne ^a   Heupel, Julia ^a   Volkert, Julia ^a   Kopf, Juliane ^a   Hilscher, Max ^a   Weber, Heike ^b   Kittel Schneider, Sarah ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Hospital of Nürtingen   (Germany)

Author keywords

Attention deficit hyperactivity disorder; Disease models; Gene expression; Methylphenidate; Microarray analysis

Indexed keywords

GLUCOSE TRANSPORTER 3; METHYLPHENIDATE; RNA; ATAXIN 1; ATXN1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; CELL RECEPTOR; GUANYLATE CYCLASE; HEY1 PROTEIN, HUMAN; MAP3K8 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NERVE PROTEIN; NEURON NAVIGATOR 2, HUMAN; ONCOPROTEIN; SLC2A3 PROTEIN, HUMAN; SOLUBLE GUANYLYL CYCLASE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; ATXN1 GENE; CELL ISOLATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GUCY1B3 GENE; HEY1 GENE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; LYMPHOBLASTOID CELL LINE; MALE; MAP3K8 GENE; MICROARRAY ANALYSIS; NAV2 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA HYBRIDIZATION; RNA ISOLATION; UPREGULATION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE CONTROL STUDY; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; ATAXIN-1; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 3; GUANYLATE CYCLASE; HUMANS; MALE; MAP KINASE KINASE KINASES; METHYLPHENIDATE; MICROARRAY ANALYSIS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; YOUNG ADULT;

EID: 84964219493     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2014.948064     Document Type: Article

References (62)

1. Alberio T, Pippione AC, Comi C, Olgiati S, Cecconi D, Zibetti M, et al. 2012. Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson ' s disease. IUBMB Life 64: 846-852
2. Aoki M, Akiyama T, Miyoshi J, Toyoshima K. 1991. Identifi cation and characterization of protein products of the cot oncogene with serine kinase activity. Oncogene 6: 1515-1519
3. Association AP. 2000. APA-American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders-DSMIV-TR Washington, DC: American Psychiatric Association
4. Barbacioru CC, Wang Y, Canales RD, Sun YA, Keys DN, Chan F, et al. 2006. Effect of various normalization methods on Applied Biosystems expression array system data. BMC Bioinformatics 7: 533
5. Bartl J, Link P, Schlosser C, Gerlach M, Schmitt A, Walitza S, et al. 2010. Effects of methylphenidate: the cellular point of view. Attent Defi c Hyperact Disord 2: 225-232
6. Biederman J. 2005. Attention-defi cit/hyperactivity disorder: a selective overview. Biol Psychiatry 57: 1215-1220
7. Bjorklund A, Dunnett SB. 2007. Dopamine neuron systems in the brain: an update. Trends Neurosci 30: 194-202
8. Brown RW, Hughes BA, Hughes AB, Sheppard AB, Perna MK, Ragsdale WL, et al. 2012. Sex and dose-related differences in methylphenidate adolescent locomotor sensitization and effects on brain-derived neurotrophic factor. J Psychopharmacol 26: 1480-1488
9. Chiariello M, Marinissen MJ, Gutkind JS. 2000. Multiple mitogen-Activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation. Mol Cell Biol 20: 1747-1758
10. Christiansen H, Kis B, Hirsch O, Matthies S, Hebebrand J, Uekermann J, et al. 2012. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specifi city. Eur Psychiatry 27: 321-328
11. Corominas-Roso M, Ramos-Quiroga JA, Ribases M, Sanchez-Mora C, Palomar G, Valero S, et al. 2013. Decreased serum levels of brain-derived neurotrophic factor in adults with attention-defi cit hyperactivity disorder. Int J Neuropsychopharmacol 1-9
12. Crespo-Barreto J, Fryer JD, Shaw CA, Orr HT, Zoghbi HY. 2010. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis .PLoS Genet 6: e1001021
13. Faraone SV, Sergeant J, Gillberg C, Biederman J. 2003. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2: 104-113
14. Franke B, Faraone SV, Asherson P, Buitelaar J, Bau CH, Ramos-Quiroga JA, et al. 2012. The genetics of attention defi cit/hyperactivity disorder in adults, a review. Mol Psychiatry 17: 960-987
15. Franke B, Neale BM, Faraone SV. 2009. Genome-wide association studies in ADHD. Hum Genet 126: 13-50
16. Fuke S, Minami N, Kokubo H, Yoshikawa A, Yasumatsu H, Sasagawa N, et al. 2006. Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system. J Neurosci Res 84: 1555-1563
17. Fuke S, Sasagawa N, Ishiura S. 2005. Identifi cation and characterization of the Hesr1/Hey1 as a candidate trans-Acting factor on gene expression through the 3 ' non-coding polymorphic region of the human dopamine transporter (DAT1) gene. J Biochem 137: 205-216
18. Fung SJ, Sivagnanasundaram S, Weickert CS. 2011. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients. Biol Psychiatry 69: 71-79
19. Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD, et al. 2012. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-Administration: a study in nonhuman primates. Neuropsychopharmacology 37: 2555-2565
20. Giorgi FM, Bolger AM, Lohse M, Usadel B. 2010. Algorithmdriven artifacts in median Polish summarization of microarray data. BMC Bioinformatics 11: 553
21. Gong R, Ding C, Hu J, Lu Y, Liu F, Mann E, et al. 2011. Role for the membrane receptor guanylyl cyclase-C in attention defi ciency and hyperactive behavior. Science 333: 1642-1646
22. Goold R, Hubank M, Hunt A, Holton J, Menon RP, Revesz T, et al. 2007. Down-regulation of the dopamine receptor D2 in mice lacking ataxin 1. Hum Mol Genet 16: 2122-2134
23. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. 2002. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41: 26S-49S. Hearst SM, Lopez ME, Shao Q, Liu Y, Vig PJ. 2010. Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation. J Neurochem 114: 706-716
24. Hoogman M, Aarts E, Zwiers M, Slaats-Willemse D, Naber M, Onnink M, et al. 2011. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am J Psychiatry 168: 1099-1106
25. Ishibashi M, Moriyoshi K, Sasai Y, Shiota K, Nakanishi S, Kageyama R. 1994. Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system. EMBO J 13: 1799-1805
26. Iso T, Kedes L, Hamamori Y. 2003. HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255
27. Kanno K, Ishiura S. 2011. Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats. J Neurosci Res 89: 562-575
28. Kim YW, Shin JC, An YS. 2009. Effects of methylphenidate on cerebral glucose metabolism in patients with impaired consciousness after acquired brain injury. Clin Neuropharmacol 32: 335-339
29. Korgun ET, Demir R, Sedlmayr P, Desoye G, Arikan GM, Puerstner P, et al. 2002. Sustained hypoglycemia affects glucose transporter expression of human blood leukocytes. Blood Cells Mol Dis 28: 152-159
30. Lee TH, Lee CH, Kim IH, Yan BC, Park JH, Kwon SH, et al. 2012. Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neurosci Lett 524: 84-88
31. Lesch KP, Selch S, Renner TJ, Jacob C, Nguyen TT, Hahn T, et al. 2011. Genome-wide copy number variation analysis in attention-defi cit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry 16: 491-503
32. Liu L, Yuan G, Cheng Z, Zhang G, Liu X, Zhang H. 2013. Identifi cation of the mRNA expression status of the dopamine d2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients. PLoS One 8: e75259
33. Maratou E, Dimitriadis G, Kollias A, Boutati E, Lambadiari V, Mitrou P, et al. 2007. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest 37: 282-290
34. Margraf J. 1994. Diagnostisches Kurzinterview bei psychischen St ö rungen: Mini-DIPS. Berlin, Heidelberg, New York: Springer Verlag
35. Marzinke MA, Mavencamp T, Duratinsky J, Clagett-Dame M. 2013. 14-3-3epsilon and NAV2 interact to regulate neurite outgrowth and axon elongation. Arch Biochem Biophys 540: 94-100
36. Matilla A, Roberson ED, Banfi S, Morales J, Armstrong DL, Burright EN, et al. 1998. Mice lacking ataxin-1 display learning defi cits and decreased hippocampal paired-pulse facilitation. J Neurosci 18: 5508-5516
37. McNeill EM, Klockner-Bormann M, Roesler EC, Talton LE, Moechars D, Clagett-Dame M. 2011. Nav2 hypomorphic mutant mice are ataxic and exhibit abnormalities in cerebellar development. Dev Biol 353: 331-343
38. Michaelides M, Pascau J, Gispert JD, Delis F, Grandy DK, Wang GJ, et al. 2010. Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. Eur J Neurosci 32: 668-676
39. Momoi T, Fujita E, Senoo H, Momoi M. 2010. Genetic factors and epigenetic factors for autism: endoplasmic reticulum stress and impaired synaptic function. Cell Biol Int 34: 13-19
40. Muley PD, McNeill EM, Marzinke MA, Knobel KM, Barr MM, Clagett-Dame M. 2008. The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation. Dev Neurobiol 68: 1441-1453
41. Pascoli V, Valjent E, Corbille AG, Corvol JC, Tassin JP, Girault JA, et al. 2005. cAMP and extracellular signal-regulated kinase signaling in response to d-Amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-Adrenoceptors. Mol Pharmacol 68: 421-429
42. Patriotis C, Makris A, Bear SE, Tsichlis PN. 1993. Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation. Proc Natl Acad Sci USA 90: 2251-2255
43. Piatkiewicz P, Czech A, Taton J, Gorski A. 2010. Investigations of cellular glucose transport and its regulation under the infl uence of insulin in human peripheral blood lymphocytes. Endokrynol Pol 61: 182-187
44. Reimold M, Globas C, Gleichmann M, Schulze M, Gerloff C, Bares R, et al. 2006. Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography. Mov Disord 21: 1667-1673
45. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, et al. 2002. [Wender Utah rating scale. The shortversion for the assessment of the attention-defi cit hyperactivity disorder in adults]. Nervenarzt 73: 830-838
46. Retz W, Reif A, Freitag CM, Retz-Junginger P, Rosler M. 2010. Association of a functional variant of neuronal nitric oxide synthase gene with self-reported impulsiveness, venturesomeness and empathy in male offenders. J Neural Transm 117: 321-324
47. Rietz CS, Hasselhorn M, Labuhn AS. 2012. Are externalizing and internalizing diffi culties of young children with spelling impairment related to their ADHD symptoms?. Dyslexia 18: 174-185
48. Rizzi TS, Arias-Vasquez A, Rommelse N, Kuntsi J, Anney R, Asherson P, et al. 2011. The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4, 963 subjects. Am J Med Genet B Neuropsychiatr Genet 156: 145-157
49. Robinson JW, Potter LR. 2012. Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain. Sci Signal 5: ra65
50. Roeske D, Ludwig KU, Neuhoff N, Becker J, Bartling J, Bruder J, et al. 2011. First genome-wide association scan on neurophysiological endophenotypes points to trans-regulation effects on SLC2A3 in dyslexic children. Mol Psychiatry 16: 97-107
51. Roget K, Ben-Addi A, Mambole-Dema A, Gantke T, Yang HT, Janzen J, et al. 2012. IkappaB kinase 2 regulates TPL-2 activa- tion of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. Mol Cell Biol 32: 4684-4690
52. Sakamoto M, Hirata H, Ohtsuka T, Bessho Y, Kageyama R. 2003. The basic helix-loop-helix genes Hesr1/Hey1 and Hesr2/Hey2egulate maintenance of neural precursor cells in the brain. J Biol Chem 278: 44808-44815
53. Selek S, Savas HA, Gergerlioglu HS, Bulut M, Yilmaz HR. 2008. Oxidative imbalance in adult attention defi cit/hyperactivity disorder. Biol Psychol 79: 256-259
54. Shayevitz C, Cohen OS, Faraone SV, Glatt SJ. 2012. A re-review of the association between the NOTCH4 locus and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 159B: 477-483
55. Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ. 2008. The facilitative glucose transporter GLUT3: 20 years of distinction. Am J Physiol Endocrinol Metab 295: E242-253
56. Van Waes V, Beverley J, Marinelli M, Steiner H. 2010. Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum. Eur J Neurosci 32: 435-447
57. Volkow ND, Fowler JS, Wang GJ, Telang F, Logan J, Wong C, et al. 2008. Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS One 3: e2017
58. Vougioukalaki M, Kanellis DC, Gkouskou K, Eliopoulos AG. 2011. Tpl2 kinase signal transduction in infl ammation and cancer. Cancer Lett 304: 80-89
59. Wanchoo SJ, Swann AC, Dafny N. 2009. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Res 1301: 68-79
60. Wettenhall JM, Smyth GK. 2004. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 20: 3705-3706
61. Yang SR, Kim SJ, Byun KH, Hutchinson B, Lee BH, Michikawa M, et al. 2006. NPC1 gene defi ciency leads to lack of neural stem cell self-renewal and abnormal differentiation through activation of p38 mitogen-Activated protein kinase signaling. Stem Cells 24: 292-298
62. Zhang C, Browne A, Child D, Divito JR, Stevenson JA, Tanzi RE. 2010. Loss of function of ATXN1 increases amyloid beta-protein levels by potentiating beta-secretase processing of beta-Amyloid precursor protein. J Biol Chem 285: 8515-8526